Therapie der chronischen Hepatitis C bei Patienten mit psychischen Erkrankungen

Suchttherapie

Volumn 6, Issue 2, 2005, Pages 66-69

  Schafer M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

drug addiction; Hepatitis C; Interferon ; psychiatric disorders; side effects

Indexed keywords

EID: 33847243398     PISSN: 14399903     EISSN: 1439989X     Source Type: Journal    
DOI: 10.1055/s-2005-858335     Document Type: Article

References (35)

1. Lynch P, Peters M, Quigley M et al. Impact of psychiatric disorders on treatment of patients with hepatitis C. Gastroenterol 1998; 114 (Suppl.):A1294
2. Shad J, Person J, Brann O. How often are referred chronic hepatitis C patients candidates for antiviral therapy. Hepatology 2000; 32: A283
3. Taruschio G, Santarini G, Sica G. Psychiatric disorders in hepatitis C virus related chronic liver disease. Gastroenterology 1996; 110: A1342
4. Taylor LE, Costello T, Alt E et al. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals. AIDS 2002; 16(12): 1700–1701
5. Dinwiddie SH, Shicker L, Newman T. Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry 2003; 160 (1): 172–174
6. Cividini A, Pistorio A, Regazzetti A et al. Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J Hepatol 1997; 27 (3): 455–463
7. Chang IT, Lin H, Yen YS et al. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwaa. J Med Virol 1993; 40(2): 170–173
8. Schaefer M, Engelbrecht MA, Gut O et al. Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26 (4): 731–746
9. McDonald EM, Mann AH, Thomas HC. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-in-terferon in hepatitis-B carriers. Lancet 1987; 2 (8569): 1175–1178
10. Renault PF, Hoofnagle JH, Park Y et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987; 147 (9): 1577–1580
11. Renault PF, Hoofnagle JH. Side effects of alpha interferon. Semin Liver Dis 1989; 9 (4): 273–277
12. Valentine AD, Meyers CA, Kling MA et al. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1998; 25 (1 Suppl 1): 39–47
13. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am J Psychiatry 2000; 157 (6): 867–876
14. Schaefer M, Schmidt F, Folwaczny C et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003; 37(2): 443–451
15. Janssen HL, Brouwer JT, van der Mast RC et al. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994; 21 (2): 241–243
16. Van Thiel DH, Friedlander L, Molloy PJ et al. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness. Eur J Gastroenterol Hepatol 1995;7(2): 165–168
17. Van Thiel DH, Anantharaju A, Creech S. Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse. Am J Gastroenterol 2003; 98 (10): 2281–2288
18. Pariante CM, Orru MG, Baita A et al. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999; 354 (9173): 131–132
19. Pariante CM, Landau S, Carpiniello B. Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis. N Engl J Med 2002; 347 (2): 148–149
20. Schaefer M, Schmidt F, Horn M et al. Depression during treatment with interferon alpha. Psychosomatics 2004; 45 (2): 176
21. Capuron L, Ravaud A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N Engl J Med 1999; 340(17): 1370
22. Sylvestre DL. Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug Alcohol Depend 2002; 67 (2): 117–123
23. Cabrera Gomez JA Jr., Cordero G, Fernandez LO et al. Treatment of schizophrenic disorder, paranoid type, with intramuscular recombinant alpha-2b interferon. Biotherapy 1993; 7(1): 27–37
24. Dobmeier M, Frick E, Frank S et al. Schizophrenic psychosis: a contraindication for treatment of hepatitis C with interferon alpha? Pharmacopsychiatry 2000; 33 (2): 72–74
25. Schafer M, Boetsch T, Laakmann G. Psychosis in a methadone-sub-stituted patient during interferon-alpha treatment of hepatitis C. Addiction 2000; 95 (7): 1101–1104
26. Schafer M, Schmidt F, Grunze H et al. [Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge]. Nervenarzt 2001; 72 (11): 872–875
27. Musselman DL, Lawson DH, Gumnick JF et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl I Med 2001; 344(13): 961–966
28. Schäfer M. Hepatitis-C-Therapie: Management psychiatrischer Nebenwirkungen von Interferon alfa. Stuttgart, New York: Georg Thieme Verlag, 2004
29. Schafer M, Schwaiger M. [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects]. Fortschr Neurol Psychiatr 2003; 71 (9): 469–476
30. Anand BS, Velez M. Influence of chronic alcohol abuse on hepatitis Cvirus replicatioa Dig Dis 2000; 18(3): 168–171
31. Anderson S, Nevins CL, Green LK et al. Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection. Dig Dis Sci 2001; 46 (7): 1393–1398
32. Bhattacharya R, Shuhart MC. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 2003; 36 (3): 242–252
33. Jamal MM, Morgan TR. Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol 2003; 17(4): 649–662
34. Peters MG. Terrault NA. Alcohol use and hepatitis C. Hepatology 2002; 36(5 Suppl 1):S220-S225
35. Zhang T, Li Y, Lai JP et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003; 38(1): 57–65